The FDA Revokes its Emergency Use Authorization for Hydroxychloroquine

Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.


Antibiotic Treatment for COVID-19 Complications Could Fuel Resistant Bacteria

Priya Nori, M.D. comments on the use of antibiotics in patients with COVID-19, which could help stem secondary bacterial infections. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.